C
Charles J. McElhinny
Researcher at Research Triangle Park
Publications - 8
Citations - 117
Charles J. McElhinny is an academic researcher from Research Triangle Park. The author has contributed to research in topics: Ligand (biochemistry) & Nociceptin receptor. The author has an hindex of 4, co-authored 8 publications receiving 113 citations.
Papers
More filters
Journal ArticleDOI
Hydrolytic instability of the important orexin 1 receptor antagonist SB-334867: possible confounding effects on in vivo and in vitro studies.
Charles J. McElhinny,Anita H. Lewin,S. Wayne Mascarella,Scott P. Runyon,Lawrence E. Brieaddy,F. Ivy Carroll +5 more
TL;DR: It is suggested that studies using SB-334867 (and any other 2-methylbenzoxazole-containing compound) should be performed with great care to avoid the confounding effects of the rapid hydrolytic decomposition of this susceptible structure.
Journal ArticleDOI
Stereospecific synthesis of amphetamines
TL;DR: In this paper, aryl lithium was added to commercially available (S)-(+)-propylene oxide to obtain the corresponding (S)aryl-2-propanol, which was obtained by conversion of the alcohol to the tosylate followed by azide displacement and hydrogenation.
Journal ArticleDOI
A Practical, Laboratory-Scale Synthesis of Perampanel
TL;DR: The orally active, noncompetitive, selective AMPA receptor antagonist Perampanel, 2-[1′,6′-dihydro- 6′-oxo-1-phenyl-(2′,3′-bipyridin)-5′-yl]benzonitrile, has been prepared from readily available, relatively inexpensive starting materials.
Journal ArticleDOI
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).
Steven D. Chang,Lawrence E. Brieaddy,Joseph D. Harvey,Anita H. Lewin,S. Wayne Mascarella,Herbert H. Seltzman,P. Anantha Reddy,Ann M. Decker,Charles J. McElhinny,Desong Zhong,Elisha E. Peterson,Hernán A. Navarro,Michael R. Bruchas,F. Ivy Carroll +13 more
TL;DR: A more efficient and convenient method of synthesis is detailed, and both in vitro and in vivo pharmacological assays are used to fully characterize this ligand, providing additional insights into the useful, systemically active, NOP receptor agonist Ro 64-6198.
Journal ArticleDOI
High specific activity (+)‐amphetamine and (+)‐methamphetamine
TL;DR: High specific activity (+)-amphetamine and (+)-methamphetamine were prepared by reductive dechlorination of (S)-(3′,5′-dichlorophenyl)-2-propylazide and (S-2′6′- dichloromethamphetamine, respectively by stereospecific total synthesis following methodology that had been previously developed in the Laboratories.